The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma

Cancer

Volumn 82, Issue 9, 1998, Pages 1698-1703

  Katase, Katsuyoshi ^a   Sugiyama, Yuko ^a   Hasumi, Katsuhiko ^a   Yoshimoto, Masataka ^a   Kasumi, Fujio ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Breast carcinoma; Endometrial carcinoma; Secondary carcinoma; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; DRUG EFFECT; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0032080487     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19980501)82:9<1698::aid-cncr16>3.0.co;2-%23     Document Type: Article

References (18)

1. Fornander T, Rutqvist LE, Cedermark B, Glas U, Mattsson A, Silfverswärd C, et al. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1989;1:117-20.
2. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM, et al. Endometrial cancer in tamoxifen-treated breast cancer patients: finding from the National Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994;86:527-37.
3. Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. J Natl Cancer Inst 1995;87:645-51.
4. FIGO News. Int J Gynaecol Obstet 1989;28:189-93.
5. Vassilakos P, Wyss R, Wenger D, Riotton G. Endometrial cytohistology by aspiration technic and by Gravlee jet washer. Obstet Gynecol 1975;45:320-4.
6. Bibbo M, Reale FR, Reale JC, Azizi F, Bartels PH, Wied GL, et al. Assessment of three sampling technics to detect endometrial cancer and its precursors. Acta Cytol 1979;23:353-9.
7. Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1975;293:1167-70.
8. Hulka BS, Chambless LE, Kaufman DG, Fowler WC, Greenberg BG. Protection against endometrial carcinoma by combination-product oral contraceptives. JAMA 1982; 247:475-7.
9. Bergkvist L, Persson I, Adami H-O, Schairer C. Risk factors for breast and endometrial cancer in a cohort of women treated with menopausal oestrogens. Int J Epidemiol 1988;17:732-7.
10. Magriples U, Naftolin F, Schwartz PE, Carcangiu ML. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 1993;11:485-90.
11. Silva EG, Tornos CS, Fallen-Mitchell M. Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen. Int J Gynecol Pathol 1994;13:248-58.
12. Boccardo F, Bruzzi P, Rubagotti A, Nicolò G, Rosso R. Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients. Oncology 1981;38:281-5.
13. Boccardo F, Guarneri D, Rubagotti A, Casertelli GL, Bentivoglio G, Conte N, et al. Endocrine effects of tamoxifen in postmenopausal breast cancer patients. Tumori 1984;70:61-8.
14. Gottardis MM, Robinson SP, Satyaswaroop PG, Jordan C. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer Res 1988; 48:812-5.
15. Anzai Y, Holinka CF, Kuramoto H, Gurpide E. Stimulatory effects of 4-hydroxytamoxifen on proliferation of human endometrial adenocarcinoma cells (Ishikawa line). Cancer Res 1989;49:2362-5.
16. Zeil HK. Estrogen's role in endometrial cancer. Obstet Gynecol 1982;60:509-15.
17. Fornander T, Hellström AC, Moberger B. Descriptive clinico-pathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer. J Natl Cancer Inst 1993;85:1850-5.
18. Rosa EC, Juan G, Mark AA, Ronald H, Stephen BE. Endometrial carcinoma associated with breast carcinoma. Cancer 1996;77:2058-63.